Recombinant Human Endostatin Market - Global Outlook and Forecast 2022-2028

January 2022 | 72 pages | ID: R374EC699596EN
Market Monitor Global

Abstracts

Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162?302 and Cys264?294.

This report contains market size and forecasts of Recombinant Human Endostatin in global, including the following market information:

Global Recombinant Human Endostatin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Recombinant Human Endostatin Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five Recombinant Human Endostatin companies in 2021 (%)

The global Recombinant Human Endostatin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Purity:95% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant Human Endostatin include Thermo Fisher Scientific and PeproTech etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Human Endostatin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Human Endostatin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Recombinant Human Endostatin Market Segment Percentages, by Type, 2021 (%)

• Purity:95%
• Others

Global Recombinant Human Endostatin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Recombinant Human Endostatin Market Segment Percentages, by Application, 2021 (%)

• Medical Care
• Scientific Research
• Others

Global Recombinant Human Endostatin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Recombinant Human Endostatin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant Human Endostatin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Recombinant Human Endostatin revenues share in global market, 2021 (%)

Key companies Recombinant Human Endostatin sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies Recombinant Human Endostatin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• PeproTech

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Recombinant Human Endostatin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Recombinant Human Endostatin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RECOMBINANT HUMAN ENDOSTATIN OVERALL MARKET SIZE

2.1 Global Recombinant Human Endostatin Market Size: 2021 VS 2028
2.2 Global Recombinant Human Endostatin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Human Endostatin Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Recombinant Human Endostatin Players in Global Market
3.2 Top Global Recombinant Human Endostatin Companies Ranked by Revenue
3.3 Global Recombinant Human Endostatin Revenue by Companies
3.4 Global Recombinant Human Endostatin Sales by Companies
3.5 Global Recombinant Human Endostatin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Human Endostatin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Human Endostatin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Human Endostatin Players in Global Market
  3.8.1 List of Global Tier 1 Recombinant Human Endostatin Companies
  3.8.2 List of Global Tier 2 and Tier 3 Recombinant Human Endostatin Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Recombinant Human Endostatin Market Size Markets, 2021 & 2028
  4.1.2 Purity:95%
  4.1.3 Others
4.2 By Type - Global Recombinant Human Endostatin Revenue & Forecasts
  4.2.1 By Type - Global Recombinant Human Endostatin Revenue, 2017-2022
  4.2.2 By Type - Global Recombinant Human Endostatin Revenue, 2023-2028
  4.2.3 By Type - Global Recombinant Human Endostatin Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Human Endostatin Sales & Forecasts
  4.3.1 By Type - Global Recombinant Human Endostatin Sales, 2017-2022
  4.3.2 By Type - Global Recombinant Human Endostatin Sales, 2023-2028
  4.3.3 By Type - Global Recombinant Human Endostatin Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Human Endostatin Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Recombinant Human Endostatin Market Size, 2021 & 2028
  5.1.2 Medical Care
  5.1.3 Scientific Research
  5.1.4 Others
5.2 By Application - Global Recombinant Human Endostatin Revenue & Forecasts
  5.2.1 By Application - Global Recombinant Human Endostatin Revenue, 2017-2022
  5.2.2 By Application - Global Recombinant Human Endostatin Revenue, 2023-2028
  5.2.3 By Application - Global Recombinant Human Endostatin Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Human Endostatin Sales & Forecasts
  5.3.1 By Application - Global Recombinant Human Endostatin Sales, 2017-2022
  5.3.2 By Application - Global Recombinant Human Endostatin Sales, 2023-2028
  5.3.3 By Application - Global Recombinant Human Endostatin Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Human Endostatin Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Recombinant Human Endostatin Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Human Endostatin Revenue & Forecasts
  6.2.1 By Region - Global Recombinant Human Endostatin Revenue, 2017-2022
  6.2.2 By Region - Global Recombinant Human Endostatin Revenue, 2023-2028
  6.2.3 By Region - Global Recombinant Human Endostatin Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Human Endostatin Sales & Forecasts
  6.3.1 By Region - Global Recombinant Human Endostatin Sales, 2017-2022
  6.3.2 By Region - Global Recombinant Human Endostatin Sales, 2023-2028
  6.3.3 By Region - Global Recombinant Human Endostatin Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Recombinant Human Endostatin Revenue, 2017-2028
  6.4.2 By Country - North America Recombinant Human Endostatin Sales, 2017-2028
  6.4.3 US Recombinant Human Endostatin Market Size, 2017-2028
  6.4.4 Canada Recombinant Human Endostatin Market Size, 2017-2028
  6.4.5 Mexico Recombinant Human Endostatin Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Recombinant Human Endostatin Revenue, 2017-2028
  6.5.2 By Country - Europe Recombinant Human Endostatin Sales, 2017-2028
  6.5.3 Germany Recombinant Human Endostatin Market Size, 2017-2028
  6.5.4 France Recombinant Human Endostatin Market Size, 2017-2028
  6.5.5 U.K. Recombinant Human Endostatin Market Size, 2017-2028
  6.5.6 Italy Recombinant Human Endostatin Market Size, 2017-2028
  6.5.7 Russia Recombinant Human Endostatin Market Size, 2017-2028
  6.5.8 Nordic Countries Recombinant Human Endostatin Market Size, 2017-2028
  6.5.9 Benelux Recombinant Human Endostatin Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Recombinant Human Endostatin Revenue, 2017-2028
  6.6.2 By Region - Asia Recombinant Human Endostatin Sales, 2017-2028
  6.6.3 China Recombinant Human Endostatin Market Size, 2017-2028
  6.6.4 Japan Recombinant Human Endostatin Market Size, 2017-2028
  6.6.5 South Korea Recombinant Human Endostatin Market Size, 2017-2028
  6.6.6 Southeast Asia Recombinant Human Endostatin Market Size, 2017-2028
  6.6.7 India Recombinant Human Endostatin Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Recombinant Human Endostatin Revenue, 2017-2028
  6.7.2 By Country - South America Recombinant Human Endostatin Sales, 2017-2028
  6.7.3 Brazil Recombinant Human Endostatin Market Size, 2017-2028
  6.7.4 Argentina Recombinant Human Endostatin Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Recombinant Human Endostatin Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Recombinant Human Endostatin Sales, 2017-2028
  6.8.3 Turkey Recombinant Human Endostatin Market Size, 2017-2028
  6.8.4 Israel Recombinant Human Endostatin Market Size, 2017-2028
  6.8.5 Saudi Arabia Recombinant Human Endostatin Market Size, 2017-2028
  6.8.6 UAE Recombinant Human Endostatin Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific Recombinant Human Endostatin Major Product Offerings
  7.1.4 Thermo Fisher Scientific Recombinant Human Endostatin Sales and Revenue in Global (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 PeproTech
  7.2.1 PeproTech Corporate Summary
  7.2.2 PeproTech Business Overview
  7.2.3 PeproTech Recombinant Human Endostatin Major Product Offerings
  7.2.4 PeproTech Recombinant Human Endostatin Sales and Revenue in Global (2017-2022)
  7.2.5 PeproTech Key News

8 GLOBAL RECOMBINANT HUMAN ENDOSTATIN PRODUCTION CAPACITY, ANALYSIS

8.1 Global Recombinant Human Endostatin Production Capacity, 2017-2028
8.2 Recombinant Human Endostatin Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Human Endostatin Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 RECOMBINANT HUMAN ENDOSTATIN SUPPLY CHAIN ANALYSIS

10.1 Recombinant Human Endostatin Industry Value Chain
10.2 Recombinant Human Endostatin Upstream Market
10.3 Recombinant Human Endostatin Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Recombinant Human Endostatin Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Recombinant Human Endostatin in Global Market
Table 2. Top Recombinant Human Endostatin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant Human Endostatin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant Human Endostatin Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant Human Endostatin Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Recombinant Human Endostatin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant Human Endostatin Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Recombinant Human Endostatin Product Type
Table 9. List of Global Tier 1 Recombinant Human Endostatin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Human Endostatin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Recombinant Human Endostatin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Recombinant Human Endostatin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Recombinant Human Endostatin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Recombinant Human Endostatin Sales (K Pcs), 2017-2022
Table 15. By Type - Global Recombinant Human Endostatin Sales (K Pcs), 2023-2028
Table 16. By Application – Global Recombinant Human Endostatin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant Human Endostatin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant Human Endostatin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant Human Endostatin Sales (K Pcs), 2017-2022
Table 20. By Application - Global Recombinant Human Endostatin Sales (K Pcs), 2023-2028
Table 21. By Region – Global Recombinant Human Endostatin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant Human Endostatin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant Human Endostatin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant Human Endostatin Sales (K Pcs), 2017-2022
Table 25. By Region - Global Recombinant Human Endostatin Sales (K Pcs), 2023-2028
Table 26. By Country - North America Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant Human Endostatin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant Human Endostatin Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Recombinant Human Endostatin Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant Human Endostatin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant Human Endostatin Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Recombinant Human Endostatin Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant Human Endostatin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant Human Endostatin Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Recombinant Human Endostatin Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant Human Endostatin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant Human Endostatin Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Recombinant Human Endostatin Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant Human Endostatin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant Human Endostatin Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant Human Endostatin Sales, (K Pcs), 2023-2028
Table 46. Thermo Fisher Scientific Corporate Summary
Table 47. Thermo Fisher Scientific Recombinant Human Endostatin Product Offerings
Table 48. Thermo Fisher Scientific Recombinant Human Endostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. PeproTech Corporate Summary
Table 50. PeproTech Recombinant Human Endostatin Product Offerings
Table 51. PeproTech Recombinant Human Endostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Recombinant Human Endostatin Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 53. Global Recombinant Human Endostatin Capacity Market Share of Key Manufacturers, 2020-2022
Table 54. Global Recombinant Human Endostatin Production by Region, 2017-2022 (K Pcs)
Table 55. Global Recombinant Human Endostatin Production by Region, 2023-2028 (K Pcs)
Table 56. Recombinant Human Endostatin Market Opportunities & Trends in Global Market
Table 57. Recombinant Human Endostatin Market Drivers in Global Market
Table 58. Recombinant Human Endostatin Market Restraints in Global Market
Table 59. Recombinant Human Endostatin Raw Materials
Table 60. Recombinant Human Endostatin Raw Materials Suppliers in Global Market
Table 61. Typical Recombinant Human Endostatin Downstream
Table 62. Recombinant Human Endostatin Downstream Clients in Global Market
Table 63. Recombinant Human Endostatin Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Human Endostatin Segment by Type
Figure 2. Recombinant Human Endostatin Segment by Application
Figure 3. Global Recombinant Human Endostatin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Recombinant Human Endostatin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Human Endostatin Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant Human Endostatin Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Human Endostatin Revenue in 2021
Figure 9. By Type - Global Recombinant Human Endostatin Sales Market Share, 2017-2028
Figure 10. By Type - Global Recombinant Human Endostatin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Recombinant Human Endostatin Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Recombinant Human Endostatin Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant Human Endostatin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant Human Endostatin Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Recombinant Human Endostatin Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant Human Endostatin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant Human Endostatin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant Human Endostatin Sales Market Share, 2017-2028
Figure 19. US Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant Human Endostatin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant Human Endostatin Sales Market Share, 2017-2028
Figure 24. Germany Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant Human Endostatin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant Human Endostatin Sales Market Share, 2017-2028
Figure 33. China Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant Human Endostatin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant Human Endostatin Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant Human Endostatin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant Human Endostatin Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant Human Endostatin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant Human Endostatin Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Recombinant Human Endostatin by Region, 2020 VS 2027
Figure 50. Recombinant Human Endostatin Industry Value Chain
Figure 51. Marketing Channels